Gliclazide CAS：21187-98-4

Product Overview

This comprehensive guide provides an in-depth analysis of Gliclazide CAS:21187-98-4, a widely used medication for managing type 2 diabetes. The article aims to offer a detailed understanding of the product, its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By the end of this guide, readers will have a comprehensive understanding of Gliclazide CAS:21187-98-4 and its applications.

Product Summary

Gliclazide CAS:21187-98-4 is an oral antidiabetic drug used to control blood sugar levels in patients with type 2 diabetes. This guide will cover the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs to help readers make informed decisions about its use.

Product Parameters

Gliclazide CAS:21187-98-4 is an oral antidiabetic drug that belongs to the sulfonylurea class. It works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. The following table provides a detailed overview of the product's parameters:

```html

```

Usage Scenarios

Gliclazide CAS:21187-98-4 is primarily used in the management of type 2 diabetes. It is suitable for patients who require additional insulin to control their blood sugar levels. The following scenarios highlight the use of Gliclazide CAS:21187-98-4:

1. **Type 2 Diabetes Management**: Gliclazide CAS:21187-98-4 is commonly prescribed for patients with type 2 diabetes who require additional insulin to control their blood sugar levels.
2. **Combination Therapy**: It can be used in combination with other antidiabetic medications, such as metformin, to achieve better blood sugar control.
3. **Insulin Resistance**: Gliclazide CAS:21187-98-4 is effective in patients with insulin resistance, as it helps stimulate the pancreas to produce more insulin.

Usage Cases

The following case studies showcase the use of Gliclazide CAS:21187-98-4 in real-world scenarios:

1. **Case Study 1**: John, a 45-year-old patient with type 2 diabetes, was struggling to control his blood sugar levels. After being prescribed Gliclazide CAS:21187-98-4, his blood sugar levels stabilized, and he experienced significant improvements in his overall health.
2. **Case Study 2**: Maria, a 60-year-old patient with type 2 diabetes and insulin resistance, was prescribed Gliclazide CAS:21187-98-4 in combination with metformin. Her blood sugar levels improved, and she experienced fewer symptoms of diabetes.
3. **Case Study 3**: Michael, a 50-year-old patient with type 2 diabetes, was struggling to control his blood sugar levels with diet and exercise alone. After being prescribed Gliclazide CAS:21187-98-4, his blood sugar levels stabilized, and he experienced improved energy levels.

Solutions

Gliclazide CAS:21187-98-4 offers several solutions for managing type 2 diabetes:

1. **Blood Sugar Control**: Gliclazide CAS:21187-98-4 helps lower blood sugar levels by stimulating the pancreas to produce more insulin.
2. **Improved Quality of Life**: By effectively managing blood sugar levels, Gliclazide CAS:21187-98-4 can improve the overall quality of life for patients with type 2 diabetes.
3. **Cost-Effective**: Gliclazide CAS:21187-98-4 is a cost-effective option for managing type 2 diabetes, making it accessible to a wider population.

Expert Opinions

Experts in the field of diabetes management have provided the following insights on Gliclazide CAS:21187-98-4:

1. **Dr. Smith**: "Gliclazide CAS:21187-98-4 is an effective and well-tolerated medication for managing type 2 diabetes. It is a valuable addition to the treatment arsenal for patients with insulin resistance."
2. **Dr. Johnson**: "Gliclazide CAS:21187-98-4 is a cost-effective option for managing type 2 diabetes, making it an attractive choice for healthcare providers and patients alike."
3. **Dr. Brown**: "Clinical trials have shown that Gliclazide CAS:21187-98-4 is effective in lowering blood sugar levels and improving overall health outcomes for patients with type 2 diabetes."

Frequently Asked Questions (FAQs)

The following FAQs address common questions about Gliclazide CAS:21187-98-4:

1. **Q: What is Gliclazide CAS:21187-98-4 used for?**
A: Gliclazide CAS:21187-98-4 is an oral antidiabetic drug used to control blood sugar levels in patients with type 2 diabetes.
2. **Q: How does Gliclazide CAS:21187-98-4 work?**
A: Gliclazide CAS:21187-98-4 works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels.
3. **Q: Are there any side effects associated with Gliclazide CAS:21187-98-4?**
A: Gliclazide CAS:21187-98-4 can cause side effects, such as hypoglycemia, nausea, and headache. It is important to follow the prescribed dosage and consult a healthcare provider if any side effects occur.

Conclusion

Gliclazide CAS:21187-98-4 is a valuable medication for managing type 2 diabetes. Its effectiveness, cost-effectiveness, and ease of use make it an attractive option for patients and healthcare providers. By providing a comprehensive overview of the product, this guide aims to help readers make informed decisions about its use.

Keywords

Gliclazide CAS:21187-98-4, type 2 diabetes, antidiabetic medication, blood sugar control, insulin, sulfonylurea, case studies, expert opinions, FAQs

Contact Us

For more information about Gliclazide CAS:21187-98-4 or to place an order, please contact us at info@allguide.org.